Avid seals manufacturing contract
Avid Bioservices is to manufacture clinical-grade material for the trials of Catalyst Biosciences’ candidate CB 813.
Avid Bioservices is to manufacture clinical-grade material for the trials of Catalyst Biosciences’ candidate CB 813.
Irish contract developer and service provider Icon is not seeing a slowdown in business from biotechnology firms despite global downturn, according to CEO Peter Gray.
Covance has defied challenging market conditions and posted positive results for the third quarter, with the company believing more major R&D outsourcing contracts are a possibility.
The NAFDAC has banned 22 firms that it says are involved in the manufacture of fake drugs from ever again selling pharmaceuticals in Nigeria, as part of a countrywide clampdown.
Isochem will have manufactured ten tonnes of the multi-purpose drug excipient vitamin E TPGS by the end of the year, marking the end of what it says has been a successful first 12 months of commercial scale production.